These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2354457

  • 1. Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma.
    Trouillas J, Girod C, Claustrat B, Joly-Pharaboz MO, Chevallier P.
    Cancer Res; 1990 Jul 01; 50(13):4081-6. PubMed ID: 2354457
    [Abstract] [Full Text] [Related]

  • 2. Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy.
    Daniel L, Trouillas J, Renaud W, Chevallier P, Gouvernet J, Rougon G, Figarella-Branger D.
    Cancer Res; 2000 Jan 01; 60(1):80-5. PubMed ID: 10646857
    [Abstract] [Full Text] [Related]

  • 3. Animal models of human pituitary tumors.
    Trouillas J, Girod C.
    Pathol Res Pract; 1988 Sep 01; 183(5):638-41. PubMed ID: 3070514
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat.
    Trouillas J, Chevallier P, Claustrat B, Hooghe-Peters E, Dubray C, Rousset B, Girod C.
    Endocrinology; 1994 Jan 01; 134(1):401-10. PubMed ID: 7903933
    [Abstract] [Full Text] [Related]

  • 5. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J, Chevallier P, Remy C, Rajas F, Cohen R, Calle A, Hooghe-Peters EL, Rousset B.
    Endocrinology; 1999 Jan 01; 140(1):13-21. PubMed ID: 9886801
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W, Ikeda H, Yoshimoto T.
    Cancer; 2002 Jul 15; 95(2):258-66. PubMed ID: 12124824
    [Abstract] [Full Text] [Related]

  • 7. Gender-related differences in prolactin secretion in pituitary prolactinomas.
    Nishioka H, Haraoka J, Akada K, Azuma S.
    Neuroradiology; 2002 May 15; 44(5):407-10. PubMed ID: 12012125
    [Abstract] [Full Text] [Related]

  • 8. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC, Parsons JA.
    Cancer Res; 1981 May 15; 41(5):1772-7. PubMed ID: 7214344
    [Abstract] [Full Text] [Related]

  • 9. Spontaneous pituitary tumors in the Wistar/Furth/Ico rat strain. An animal model of human prolactin adenoma.
    Trouillas J, Girod C, Claustrat B, Curé M, Dubois MP.
    Am J Pathol; 1982 Oct 15; 109(1):57-70. PubMed ID: 7124908
    [Abstract] [Full Text] [Related]

  • 10. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents].
    Gao L, Xu JP, Shan HM, Zhang R, Xu RK.
    Sheng Li Xue Bao; 2001 Jun 15; 53(3):165-9. PubMed ID: 12589398
    [Abstract] [Full Text] [Related]

  • 11. Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.
    Maeda T, Sawada K, Itoh Y, Moriwaki K, Mori H.
    Lab Invest; 1991 Dec 15; 65(6):679-87. PubMed ID: 1753713
    [Abstract] [Full Text] [Related]

  • 12. Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas.
    Talan-Hranilović J, Gnjidić Z, Sajko T, Vizner B, Vrkljan M.
    Acta Med Croatica; 2000 Dec 15; 54(2):59-63. PubMed ID: 11028110
    [Abstract] [Full Text] [Related]

  • 13. Diethylstilbestrol-induced prolactinoma: dose-related tumor growth and effect of catecholaminergic cells on prolactin tumor cells.
    Palaoğlu S, Sungur A, Cila A, Ozdemir N, Ruacan S.
    Surg Neurol; 2005 Dec 15; 64 Suppl 2():S42-7. PubMed ID: 16256840
    [Abstract] [Full Text] [Related]

  • 14. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D.
    Mol Cancer; 2007 Jan 12; 6():4. PubMed ID: 17222350
    [Abstract] [Full Text] [Related]

  • 15. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors.
    Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M, Perrin G, Fèvre-Montange M, Rey C, Figarella-Branger D, Raverot G, Belin MF, Lachuer J, Trouillas J.
    Endocr Relat Cancer; 2007 Sep 12; 14(3):887-900. PubMed ID: 17914117
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.
    Gruszka A, Pawlikowski M, Kunert-Radek J.
    Neuro Endocrinol Lett; 2001 Oct 12; 22(5):343-8. PubMed ID: 11600876
    [Abstract] [Full Text] [Related]

  • 17. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK, Wu XM, Di AK, Xu JN, Pang CS, Pang SF.
    Biol Signals Recept; 2000 Oct 12; 9(1):1-20. PubMed ID: 10686432
    [Abstract] [Full Text] [Related]

  • 18. Functional and morphological characteristics of transplantable rat pituitary tumors established in nude mice.
    Makino S, Mori H, Koizumi K, Yamashita H, Hayashi Y, Aono T, Matsumoto K.
    Cancer Res; 1984 Oct 12; 44(10):4487-95. PubMed ID: 6540621
    [Abstract] [Full Text] [Related]

  • 19. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
    Gao L, Yang QH, Xu RK.
    Sheng Li Xue Bao; 2005 Jun 25; 57(3):319-27. PubMed ID: 15968426
    [Abstract] [Full Text] [Related]

  • 20. Three-dimensional imaging of hormone-secreting cells and their microvessel environment in estrogen-induced prolactinoma of the rat pituitary gland by confocal laser scanning microscopy.
    Itoh J, Kawai K, Serizawa A, Yamamoto Y, Ogawa K, Matsuno A, Watanabe K, Osamura RY.
    Appl Immunohistochem Mol Morphol; 2001 Dec 25; 9(4):364-70. PubMed ID: 11759065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.